Form 4: Masimo EVP, Business Development, Tao Levy, Terminates Employment; Unvested RSUs Fully Vested

Masimo Corporation's Executive Vice President of Business Development, Tao Levy, terminated employment on November 13, 2024, resulting in the full vesting of his unvested restricted stock units.

Summary

• Tao Levy, Executive Vice President of Business Development at Masimo Corporation, had his employment terminated on November 13, 2024.
• This termination was part of Masimo's strategic shift to refocus on its core healthcare business.
• As a result of the termination, 30,000 unvested restricted stock units (RSUs) held by Mr. Levy vested in full.
• The vesting of these RSUs was triggered by a 'covered termination' as defined in the Masimo Corporation 2017 Equity Incentive Plan.
• Additionally, 14,398 shares were withheld by the issuer to cover tax obligations related to the vesting of the RSUs.

Sentiment

Score: 4

Explanation: The document indicates a significant change in leadership and strategy, which could introduce uncertainty. While the vesting of RSUs is a standard procedure, the termination of a key executive is generally viewed with caution by investors.

Negatives

• The termination of the EVP of Business Development could indicate a change in strategy or potential instability within the company's leadership.

Risks

• The departure of a key executive like the EVP of Business Development could impact the company's strategic initiatives and business development efforts.
• The strategic shift to refocus on the core healthcare business may lead to uncertainty in other areas of the company.

Management Comments

• Masimo Corporation is strategically shifting to refocus on its core healthcare business.

Industry Context

Executive departures and strategic shifts are not uncommon in the healthcare technology industry, often reflecting changes in market conditions or company priorities. This move could signal a renewed focus on core competencies for Masimo.

Comparison to Industry Standards

• Executive departures are a common occurrence in the corporate world, and the vesting of equity upon termination is a standard practice.
• The number of RSUs granted and vested is specific to the individual's compensation package and company policy, making direct comparisons difficult without further context.
• Companies like Medtronic and Abbott also use equity-based compensation, but the specific terms and vesting schedules vary.

Management Changes

Stakeholder Impact

• Shareholders may react to the news of an executive departure and strategic shift.
• Employees may experience uncertainty due to the change in leadership and company direction.

Key Dates

Keywords

Masimo, Tao Levy, Executive Termination, Restricted Stock Units, RSU Vesting, Business Development, Healthcare, Strategic Shift